CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Back to all Representative Matters
Aug 10, 2020

Energy+ Closes $55 Million Offering of Unsecured Debentures

Jill P. Fraser, Melanie Cole and Meredith McCann

On August 10, 2020, Energy+ Inc. closed a $55 million offering of 2.968% senior unsecured debentures due August 10, 2060. The debentures were sold on an agency basis to accredited investors on a private placement basis by means of a confidential offering memorandum.

The net proceeds from the sale of the debentures will be used for capital expenditures and for general corporate purposes. In addition, Energy+ used a portion of the proceeds of the offering to repay $35 million of indebtedness maturing in 2020.

Aird & Berlis represented Energy+ with a team led by Jill Fraser and assisted by Melanie Cole and Meredith McCann.

Related Representative Matters

Representative Matters
Feronia Inc. Completes Restructuring Transaction Richard M. Kimel, Amy Marcen-Gaudaur, Steven L. Graff, Kyle B. Plunkett and Nathan Gates Nov 19, 2020 Feronia Inc. recently completed a third party sale and restructuring transaction, resulting in th... Feronia Inc. recently completed a third party sale and restructuring transaction, resulting in the sale of substantially all of the Company’s assets, including its direct and indirect equity interests in its operating subsidiary, Plantations et Huileries du Congo.
Representative Matters
MediPharm Labs Completes $37.8 Million Private Placement Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins Jun 22, 2020 MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cann... MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor for aggregate gross proceeds of $37,822,500.
Representative Matters
TD Bank Leads $64 Million Syndicated Credit Facilities Jill P. Fraser and Kyle B. Plunkett Oct 23, 2019 Sangoma Technologies Inc. and Sangoma U.S. Inc. entered into a syndicated loan agreement with certain Schedule 1 banks.